SARS-CoV-2 Variants and Vaccines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34161052.
- Also identified by DOI 10.1056/NEJMsr2105280 and PMC identifier 8262623.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- SARS-CoV-2